CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 266 filers reported holding CYTOKINETICS INC in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,135 | +35.0% | 32,241 | +75.6% | 0.02% | +5.9% |
Q4 2022 | $841 | -100.0% | 18,363 | -71.2% | 0.02% | -74.6% |
Q3 2022 | $3,094,000 | +156.6% | 63,858 | +108.0% | 0.07% | +109.4% |
Q2 2022 | $1,206,000 | +150.7% | 30,704 | +26.3% | 0.03% | +255.6% |
Q2 2021 | $481,000 | -54.8% | 24,317 | -46.9% | 0.01% | -57.1% |
Q1 2021 | $1,065,000 | +217.0% | 45,792 | +75.0% | 0.02% | +110.0% |
Q1 2017 | $336,000 | +60.8% | 26,166 | +51.8% | 0.01% | +100.0% |
Q4 2016 | $209,000 | -44.9% | 17,240 | -58.3% | 0.01% | -44.4% |
Q3 2016 | $379,000 | +142.9% | 41,300 | +150.8% | 0.01% | +200.0% |
Q2 2016 | $156,000 | +47.2% | 16,470 | +9.7% | 0.00% | 0.0% |
Q1 2016 | $106,000 | -63.3% | 15,008 | -45.8% | 0.00% | -62.5% |
Q4 2015 | $289,000 | +120.6% | 27,672 | +41.2% | 0.01% | +100.0% |
Q3 2015 | $131,000 | +13.9% | 19,592 | +14.6% | 0.00% | +33.3% |
Q2 2015 | $115,000 | -30.7% | 17,091 | -30.2% | 0.00% | -40.0% |
Q1 2015 | $166,000 | +61.2% | 24,493 | +90.2% | 0.01% | +25.0% |
Q4 2014 | $103,000 | +106.0% | 12,878 | -9.5% | 0.00% | +100.0% |
Q3 2014 | $50,000 | -73.1% | 14,228 | -63.5% | 0.00% | -71.4% |
Q2 2014 | $186,000 | – | 38,969 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |